Compound details
Tiegusanin I
| Compound ID | CDAMM02245 |
|---|---|
| Common name | Tiegusanin I | IUPAC name | (3,4,5,19-tetramethoxy-9,10-dimethyl-11-propanoyloxy-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaen-8-yl) 2-methylbut-2-enoate |
| Molecular formula | C31H38O10 |
| Retention time | 15.19 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 571.254 | Theoretical mz | 571.253 |
| Error | 0.74 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.9578 |
| Inchi key | BTKZCBGTFRTOHM-XNTDXEJSNA-N |
|---|---|
| Smiles | O=C(OC1C=2C=C(OC)C(OC)=C(OC)C2C3=C(OC)C=4OCOC4C=C3C(OC(=O)CC)C(C)C1C)C(=CC)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Tannins |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |